Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-028589
Filing Date
2020-03-03
Accepted
2020-03-03 16:41:34
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 tm2011417d1_424b5.htm 424B5 391034
2 GRAPHIC tm2011417d1-424b5img3.jpg GRAPHIC 21990
3 GRAPHIC tm2011417d1_424b5img001.jpg GRAPHIC 51248
4 GRAPHIC tm2011417d1_424b5img002.jpg GRAPHIC 21024
5 GRAPHIC tm2011417d1base_img1.jpg GRAPHIC 21844
6 GRAPHIC tm2011417d1base_img2.jpg GRAPHIC 92769
  Complete submission text file 0001104659-20-028589.txt   680753
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-232122 | Film No.: 20683043
SIC: 2834 Pharmaceutical Preparations